MedPath
HSA Approval

Winlevi Cream 1% w/w

SIN17072P

Winlevi Cream 1% w/w

Winlevi Cream 1% w/w

August 28, 2024

HYPHENS PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantHYPHENS PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CREAM

TOPICAL

Medical Information

D10AX06

Manufacturer Information

HYPHENS PHARMA PTE. LTD.

Cosmo S.p.A.

Active Ingredients

Clascoterone

1% w/w

Clascoterone

Documents

Package Inserts

Winlevi Cream 1% PI.pdf

Approved: August 28, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Winlevi Cream 1% w/w - HSA Approval | MedPath